Skip to main content
Fig. 1 | BMC Ophthalmology

Fig. 1

From: Markedly increased ocular side effect causing severe vision deterioration after chemotherapy using new or investigational epidermal or fibroblast growth factor receptor inhibitors

Fig. 1

EGFR and FGFR inhibitors and their corneal epithelial changes. EGFR = epidermal growth factor receptor, FGFR = fibroblast growth factor receptor, OPH = ophthalmology department, BBB = blood-brain barrier, mAb = monoclonal antibody, Ab-ADC = antibody-drug conjugate, TKI = tyrosine kinase inhibitor

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us